Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,33 USD | -2,20% | -2,02% | +41,76% |
15/04 | CorMedix Inc. kondigt aan dat DefenCath®? (Taurolidine en heparine) aan | CI |
08/04 | Sectorupdate: Aandelen gezondheidszorg dalen aan het eind van de middag | MT |
Vakgebied
Aantal werknemers: 83
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 48 | 18-03-22 |
Mathew David
DFI | Director of Finance/CFO | 47 | 11-05-20 |
Tushar Mukherjee
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-22 |
General Counsel | - | 12/12 | |
Erin Mistry
PRN | Corporate Officer/Principal | 43 | 01-01-20 |
Frank Raffaele
PRN | Corporate Officer/Principal | - | 12-05-22 |
Donna Ucci
PRN | Corporate Officer/Principal | - | 12-05-22 |
Corporate Officer/Principal | 45 | 01-03-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Myron Kaplan
CHM | Chairman | 79 | 27-04-16 |
Steven Lefkowitz
DFI | Director of Finance/CFO | 68 | 15-08-11 |
Alan Dunton
BRD | Director/Board Member | 70 | 01-03-19 |
Janet Dillione
BRD | Director/Board Member | 65 | 06-08-15 |
Joseph Todisco
CEO | Chief Executive Officer | 48 | 18-03-22 |
Gregory Duncan
BRD | Director/Board Member | 59 | 02-11-20 |
Robert Stewart
BRD | Director/Board Member | 56 | 13-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 54 981 102 | 54 425 049 ( 98,99 %) | 0 | 98,99 % |
Aandeel B | 0 | 181 622 | 0 | 0 |
Bedrijfsgegevens
CorMedix, Inc.
300 Connell Drive Suite 4200
07922, Berkeley Heights
+908 517 9500
http://www.cormedix.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,76% | 293 mln. | |
+3,96% | 70,78 mld. | |
+10,72% | 9,15 mld. | |
-15,34% | 4,84 mld. | |
+34,54% | 4,22 mld. | |
+5,09% | 3,92 mld. | |
+21,10% | 2,55 mld. | |
-28,33% | 2,24 mld. | |
-24,15% | 2,26 mld. | |
+6,23% | 1,92 mld. |
- Beurs
- Aandelen
- Koers CRMD
- Onderneming CorMedix Inc.